Back to News
Market Impact: 0.1
Medicenna Completes Phase 1/2 ABILITY-1 Enrollment and Announces Webinar to Discuss Updated MDNA11 Results with Key Opinion Leaders
Source: globenewswire.com
Healthcare & Biotech
The company said it will present updated data at SITC 2026 and host a key opinion leaders webinar on November 10. The text provides no data, product, or financial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- CVS Plans to Break Up $117 Billion Healthcare Conglomerate
- How Abdul El-Sayed would build Medicare for All, from a wealth tax to a Fed-style governing board
- BillionToOne SVP John ten Bosch sells $320,723 in stock
- Novo raises full-year outlook as Wegovy sales impress
- Sight Sciences earnings missed by $0.48, revenue topped estimates
- Novo CEO Doustdar 'Very Optimistic' About CagriSema